Mark E. Schnute - Concepedia

Concepedia

Author

Mark E. Schnute

Pfizer (United States)ORCID

Also Known As

B. Collins, M. E. SCHNUTE, M. E. Schnute, M.E. Schnute, MARK E. SCHNUTE, Mark E Schnute, Mark E. Schnute, Mark Schnute, Mark E. Schnute, Schnute, M.E.

55

Publications

2.3K

Citations

25

H-Index

58

Concepts

All Affiliations

Pfizer (United States)University of Illinois Urbana-Champaign

ME

About

Mark E. Schnute is an author at Pfizer (United States) specializing in pharmacology, medicine, and chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	1.1K
2	Natural Sciences	9	9	713
3	Biochemistry	9	9	681
4	Engineering	6	6	394
5	Allergy	1	1	27

Mark E. Schnute

×

30

Publications

2.3K

Citations

25

H-Index

	Year	Citations
A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors Bryan Lanning, Landon R. Whitby, Melissa M. Dix, Nature Chemical Biology Molecular DockingDrug TargetBiochemistryNatural SciencesRoad Map	2014	356
Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1 Mark E. Schnute, Matthew D. McReynolds, Tom Kasten, Biochemical Journal Specific InhibitorWhole BloodCellular PhysiologySignaling PathwayCell Regulation	2012	274
A Novel Autotaxin Inhibitor Reduces Lysophosphatidic Acid Levels in Plasma and the Site of Inflammation James K. Gierse, Atli Thorarensen, Konstantine Beltey, Journal of Pharmacology and Experimental Therapeutics	2010	226
The First Formal Asymmetric Synthesis of Phorbol Paul A. Wender, Kenneth D. Rice, Mark E. Schnute Journal of the American Chemical Society Altmetric Attention ScoreChemometricsOrganic ChemistrySocial Media PresenceChemistry	1997	195
Chemistry of Enoxysilacyclobutanes: Highly Selective Uncatalyzed Aldol Additions Scott E. Denmark, Brian D. Griedel, Diane M. Coe, Journal of the American Chemical Society Molecular SciencesEngineeringChemical AnalysisDonut IconMedicine	1994	154
Selective Inhibition of BTK Prevents Murine Lupus and Antibody-Mediated Glomerulonephritis Andrew L. Rankin, Nilufer P. Seth, Sean Keegan, The Journal of Immunology	2013	108
Gas-phase acidities of carboxylic acids and alcohols from collision-induced dissociation of dimer cluster ions Susan T. Graul, Mark E. Schnute, Robert R. Squires International Journal of Mass Spectrometry and Ion Processes Molecular KineticsGas-phase AciditiesEngineeringNatural SciencesDimer Cluster Ions	1990	88
Cartilage degradation biomarkers predict efficacy of a novel, highly selective matrix metalloproteinase 13 inhibitor in a dog model of osteoarthritis: Confirmation by multivariate analysis that modulation of type ii collagen and aggrecan degradation peptides parallels pathologic changes Steven L. Settle, Lillian Vickery, Olga V. Nemirovskiy, Arthritis & Rheumatism	2010	69
Structural and Inhibition Analysis Reveals the Mechanism of Selectivity of a Series of Aggrecanase Inhibitors Micky D. Tortorella, Alfredo G. Tomasselli, Karl J. Mathis, Journal of Biological Chemistry Aggrecanase InhibitorsBioorganic ChemistryGlycobiologyMolecular BiologyPolysaccharide	2009	63
Imidazo[1,5-a]quinoxalines as irreversible BTK inhibitors for the treatment of rheumatoid arthritis Kyung‐Hee Kim, Andreas Maderna, Mark E. Schnute, Bioorganic & Medicinal Chemistry Letters Rheumatoid DisorderRheumatologyMedicinal ChemistryAnti-inflammatoryMedicine	2011	63

Page 1